231 related articles for article (PubMed ID: 12515256)
1. Experts confirm statins' safety but advise caution with certain patients.
Levenson D
Rep Med Guidel Outcomes Res; 2002 Jul; 13(13):1-2, 5. PubMed ID: 12515256
[No Abstract] [Full Text] [Related]
2. When a statin fails.
Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
[No Abstract] [Full Text] [Related]
3. Side effects of statins--prevalence, relevance, consequences.
Sinzinger H
Wien Klin Wochenschr; 2002 Nov; 114(21-22):887-8. PubMed ID: 12528318
[No Abstract] [Full Text] [Related]
4. [Statins in practice of the vascular surgeon and cardiologist].
Pokrovskiĭ AV; Suntsov DS
Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
[TBL] [Abstract][Full Text] [Related]
5. Statins "R" us. Pediatricians call for cholesterol-lowering drugs for some kids. Is this a quick fix for obesity's ills?
Park A
Time; 2008 Jul; 172(3):58. PubMed ID: 18655389
[No Abstract] [Full Text] [Related]
6. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
Barter PJ; Rye KA
Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953
[No Abstract] [Full Text] [Related]
7. Statins as cardioprotective agents.
Piskur JR; Stone NJ
Am J Manag Care; 2002 Jun; 8(9 Suppl):25-9. PubMed ID: 12099325
[No Abstract] [Full Text] [Related]
8. What you should know about: statins.
Harv Health Lett; 2012 Oct; 37(12):7. PubMed ID: 23243693
[No Abstract] [Full Text] [Related]
9. Lipid management with statins. The lower the better?
Laufs U; Liao JK; Böhm M
Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235
[TBL] [Abstract][Full Text] [Related]
10. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
Capriotti T
Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
[No Abstract] [Full Text] [Related]
11. [Is statin treatment for children safe and effective?].
Marchetti F; Cannioto Z
Recenti Prog Med; 2008 Dec; 99(12):599-601. PubMed ID: 19388217
[TBL] [Abstract][Full Text] [Related]
12. Statins.
McLoughlin C
Prof Nurse; 2004 Jul; 19(11):51-2. PubMed ID: 15317342
[TBL] [Abstract][Full Text] [Related]
13. Intensive lipid-lowering therapy: obvious benefits, possible risks.
Zimlichman E; Szyper-Kravitz M; Katz U; Shoenfeld Y
Isr Med Assoc J; 2006 Dec; 8(12):890-1. PubMed ID: 17214117
[No Abstract] [Full Text] [Related]
14. Lipid-lowering therapy--benefits and risks.
Abinader EG
Isr Med Assoc J; 2007 Feb; 9(2):132-3; author reply 133-4. PubMed ID: 17354321
[No Abstract] [Full Text] [Related]
15. Myopathy caused by a combination rosuvastatin and fenofibrate.
Dedhia V; Munsi SC
J Assoc Physicians India; 2007 Feb; 55():152-3. PubMed ID: 17571748
[No Abstract] [Full Text] [Related]
16. Updated guidelines support even lower cholesterol levels for at-risk patients.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
[No Abstract] [Full Text] [Related]
17. Statins and coenzyme Q10.
Ellis CJ; Scott R
Lancet; 2003 Mar; 361(9363):1134-5. PubMed ID: 12672343
[No Abstract] [Full Text] [Related]
18. [Interactions between statins and macrolide antibiotics].
Molden E; Andersson KS; Jacobsen D
Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1660-1. PubMed ID: 17571108
[No Abstract] [Full Text] [Related]
19. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Koro CE; Sowell MO; Stender M; Qizilbash N
Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
[TBL] [Abstract][Full Text] [Related]
20. Lipid-lowering therapy--benefits and risks.
Shechter M
Isr Med Assoc J; 2007 Feb; 9(2):133; author reply 133-4. PubMed ID: 17348492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
